Future Events

EULAR 2025 MCTC meeting session
2025 June 12, Thu
12:00~13:00 (Barcelona time, GMT+2)
Room 8.36, Hall 8, CC8 (Upper Floor),
Fira de Barcelona, Gran Via venue (EULAR Congress Venue)
This session will provide an opportunity to share progress, highlight new initiatives, and strengthen our global collaborations.
We will discuss ongoing projects, future directions, and hear directly from patients about their perspectives on clinical trial participation.
Agenda Highlights include:
– Patient voice in clinical trials – key challenges and unmet needs
– Overview of MCTC activities
– Project updates
– Industry partnerships and collaborations
– New project proposals
Past Events

MCTC IIM-ILD 1st Project Team Meeting
2025/05/19 11:00-12:00 (EST)
Online
Our first IIM-ILD Project Team meeting focused on aligning the goals and plans of the three subprojects.
We will continue to provide quarterly updates to all working group members on the progress.

MCTC IIM-ILD Working Group Meeting 2025 Q1
2025 March 27 Thu
10:00~11:00 (EST)
Online
This initiative is specifically designed to address the urgent, unmet needs of clinical trials in the area of ILD with IIM.

MCTC General Body Meeting
2025 March 19 Wed
10:00~11:00 (EST)
Online
2024 Progress Report and Introduction to 2025 Projects for MCTC Members!
We briefly presented our 2024 progress, including membership recruitment, the investigator survey, and MCTC publications. We also introduceed our project plans for 2025.

ACR 2024 MCTC/Cure JM session
2024/11/17 17:30-18:30 (EST)
Embassy Suites DC Convention Center
900 10th Street, NW
Washington DC, 20001
Room: Capital CD, Classrom setup
Thank you to everyone who joined our in-person session! The MCTC core team shared our vision and future plans for myositis clinical trials. We had productive discussions on challenges and solutions in JDM trials, focusing on pediatric committee requirements.
Your insights were invaluable—stay tuned for our next steps!

Industry Roundtable
2024/10/23 10:00~11:30 (EST)
Online
An open event for industry interested in myositis including all forms of myositis as well as myositis ILD.
We will discuss about how the MCTC can best partner with the pharmaceutical industry to solve critical issues affecting clinical trials in autoimmune myositis, develop centers of excellence in myositis and find effective treatments